Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-10-10 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
PRELIMINARY Q3 RESULTS & UPDATED FY 2024 GUIDANCE
Regulatory Filings
2024-10-10 English
Preliminary Q3 Results & Updated FY 2024 Guidance
Earnings Release Classification · 100% confidence The document is a press release dated October 10, 2024, issued by Indivior PLC via the RNS (Regulatory News Service) number 7317H. The content explicitly states it provides 'Preliminary Q3 2024 financial results' and 'Updated FY 2024 Guidance'. This structure—announcing preliminary results and updated guidance for a specific period (Q3 2024) before the full report is issued—is characteristic of an Earnings Release (ER). It is not the full Quarterly Report (IR) as it focuses on highlights and guidance updates, nor is it a Report Publication Announcement (RPA) because it contains substantial financial data and commentary, rather than just announcing the availability of another document. The presence of the RNS header and the nature of the content strongly point to an Earnings Release. Q3 2024
2024-10-10 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-10-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT' and details the purchase of 391,693 ordinary shares for cancellation under a Share Repurchase Program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase activities. Although it is distributed via RNS, the core content is a specific transaction report, making POS the most accurate classification over the general RNS fallback.
2024-10-08 English
SC 13D
Major Shareholding Notification
2024-10-04 English
CHAIR SUCCESSION PLAN
Regulatory Filings
2024-10-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.